0
Journal Contents   |    
PAROSTEAL (JUXTACORTICAL) OSTEOGENIC SARCOMA
Leonard A. Dwinnell; David C. Dahlin; Ralph K. Ghormley
View Disclosures and Other Information
Rochester, Minnesota Section of Surgical Pathology, Mayo Clinic Section of Orthopaedic Surgery, Mayo Clinic and Mayo Foundation
1954 by The Journal of Bone and Joint Surgery, Incorporated
The Journal of Bone & Joint Surgery.  1954; 36:732-744 
5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case
text A A A

Abstract

On the basis of a study of fifteen cases of parosteal osteogenic sarcoma, we concluded:

1. Parosteal osteogenic sarcoma is a recognizable clinicopathological entity which is unusual because of its low degree of malignancy. The history and roentgenographic appearance should lead the surgeon and the pathologist to suspect the diagnosis. Careful histological examination will confirm it.

2. In the past this type of tumor has commonly been believed to be a benign one, such as atypical osteochondroma or a strange recurring form of myositis ossificans. It is the authors' opinion that the lesions are usually malignant from the beginning.

3. The statement that "each neoplasm has its own . . . criteria governing benignity or malignancy"11 is again emphasized in respect to this tumor.

Figures in this Article
    This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

    Topics

    Accreditation Statement
    These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of Orthopaedic Surgeons and The Journal of Bone and Joint Surgery, Inc. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
    CME Activities Associated with This Article
    Submit a Comment
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discretion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe




    Related Articles
    Related Cases
    Related Content
    Topic Collections
    Related Audio and Videos
    PubMed Articles
    ERK5 regulates invasiveness of osteosarcoma by inducing MMP-9.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society: Issue date- 2011 Dec 29
    Clinical Trials
    Readers of This Also Read...
    jbjs jobs
    12/22/2011
    VA - Charleston Area Medical Center
    12/22/2011
    ME - Central Maine Medical Center